Biopharmaceuticals

Results: 91



#Item
71Incoming Letter: Nabi Biopharmaceuticals/Biota Holdings Limited

Incoming Letter: Nabi Biopharmaceuticals/Biota Holdings Limited

Add to Reading List

Source URL: www.sec.gov

Language: English - Date: 2012-06-20 13:15:06
72Chromatographic Purification of Biopharmaceuticals Process Understanding, Novel Materials, and Product Quality by Design Physical & Environmental Sciences & Engineering School of Engineering and Applied Science, Departme

Chromatographic Purification of Biopharmaceuticals Process Understanding, Novel Materials, and Product Quality by Design Physical & Environmental Sciences & Engineering School of Engineering and Applied Science, Departme

Add to Reading List

Source URL: www.virginia.edu

Language: English - Date: 2011-03-16 13:41:13
73Table 3 Venture Capital Investment Activity by Sector 2005 Financings INDUSTRY Biopharmaceuticals

Table 3 Venture Capital Investment Activity by Sector 2005 Financings INDUSTRY Biopharmaceuticals

Add to Reading List

Source URL: www.cvca.ca

Language: English - Date: 2012-04-13 12:53:19
74Table 3 Venture Capital Investment Activity by Sector 2006 Financings INDUSTRY Biopharmaceuticals

Table 3 Venture Capital Investment Activity by Sector 2006 Financings INDUSTRY Biopharmaceuticals

Add to Reading List

Source URL: www.cvca.ca

Language: English - Date: 2012-04-13 12:47:53
75Total VC Investment Activity by Sector 2007 Sector (All) a. Life Sciences Biopharmaceuticals Healthcare

Total VC Investment Activity by Sector 2007 Sector (All) a. Life Sciences Biopharmaceuticals Healthcare

Add to Reading List

Source URL: www.cvca.ca

- Date: 2012-04-13 12:53:55
    76Disclosure Form: Christopher R. Snell

    Disclosure Form: Christopher R. Snell

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    77Production and Control of Biosimilars versus Innovators Antonio da Silva, Head Preclinical Development Hexal / Sandoz Biopharmaceuticals Lisbon, 03 April 2013 © 2013 Hexal AG, All rights reserved. All trademarks are the

    Production and Control of Biosimilars versus Innovators Antonio da Silva, Head Preclinical Development Hexal / Sandoz Biopharmaceuticals Lisbon, 03 April 2013 © 2013 Hexal AG, All rights reserved. All trademarks are the

    Add to Reading List

    Source URL: www.egagenerics.com

    Language: English
    78XTL Biopharmaceuticals Retains Expert Consultants in Rheumatology for Phase II Lupus Trial HERZLIYA, Israel – March 25, 2014 – XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) (“XTL” or the

    XTL Biopharmaceuticals Retains Expert Consultants in Rheumatology for Phase II Lupus Trial HERZLIYA, Israel – March 25, 2014 – XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) (“XTL” or the "Company"), a cli

    Add to Reading List

    Source URL: www.xtlbio.com

    Language: English - Date: 2014-03-25 09:57:16
    79  	
      Alder BioPharmaceuticals Added to Russell 3000® Index

          Alder BioPharmaceuticals Added to Russell 3000® Index

    Add to Reading List

    Source URL: www.alderbio.com

    Language: English - Date: 2014-06-27 02:19:03
    80CASE STUDY  The Commercial Issue MVM Life Science Partners was founded in 1997 and invests funds totalling $500 million in the fields of biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare IT, health

    CASE STUDY The Commercial Issue MVM Life Science Partners was founded in 1997 and invests funds totalling $500 million in the fields of biopharmaceuticals, diagnostics, drug delivery, gene therapy, healthcare IT, health

    Add to Reading List

    Source URL: www.jakemp.com

    Language: English - Date: 2014-04-29 04:13:06